North Capital’s ETRACS Alerian MLP Index ETN Series B due July 18 2042 AMUB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.89M Sell
87,219
-911
-1% -$20K 1.43% 12
2026
Q1
$1.91M Buy
88,130
+929
+1% +$19.4K 1.62% 10
2025
Q4
$1.65M Sell
87,201
-1,893
-2% -$35.4K 1.42% 12
2025
Q3
$1.65M Buy
89,094
+2,052
+2% +$39.2K 1.28% 13
2025
Q2
$1.67M Sell
87,042
-16
-0% -$303 1.44% 13
2025
Q1
$1.78M Buy
+87,058
New +$1.75M 1.68% 10

North Capital's AMUB Position: Q2 2026 in Review

North Capital reduced its ETRACS Alerian MLP Index ETN Series B due July 18 2042 (AMUB) stake by 1% in Q2 2026, selling an estimated $20K and leaving 87,219 shares worth $1.89M. The position accounts for 1.43% of the portfolio, ranked #12.

North Capital first reported a position in AMUB in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.91M in Q1 2026. 1 fund tracked by Wall St. Rank holds AMUB as of Q2 2026.

  • North Capital held 87,219 shares of ETRACS Alerian MLP Index ETN Series B due July 18 2042 worth $1.89M as of Q2 2026.
  • North Capital sold 911 ETRACS Alerian MLP Index ETN Series B due July 18 2042 shares in Q2 2026, an estimated $20K.
  • ETRACS Alerian MLP Index ETN Series B due July 18 2042 made up 1.43% of North Capital's portfolio in Q2 2026, its #12 holding.
  • North Capital first reported a position in ETRACS Alerian MLP Index ETN Series B due July 18 2042 in Q1 2025 and has held it in 6 quarters since.
  • North Capital's ETRACS Alerian MLP Index ETN Series B due July 18 2042 position peaked at $1.91M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held ETRACS Alerian MLP Index ETN Series B due July 18 2042 as of Q2 2026.

Based on North Capital's 13F filing for Q2 2026, filed 14 Jul 2026.